This is a renewal, not an expansion of capital return. Plexus authorized another $100.0 million program, but it only begins after the existing $100.0 million authorization expires; just $9.6 million remained under that current program as of August 19, 2026. (Share repurchase program)
The direction was partly anticipated, making the filing more confirmation than surprise. Management had already indicated it would discuss the next authorization with the board in August, so the existence of a replacement program was broadly signaled rather than a fresh strategic pivot.
The key limitation is that the authorization is not a promise to spend $100 million soon. Plexus gave no schedule or minimum commitment, leaving actual repurchases dependent on market conditions, financing and other considerations. (Share repurchase program) 〔0〕
Net read: in line with the standing expectation, with no incremental earnings or cash-flow signal. The filing preserves shareholder-return capacity but does not increase the authorized amount, accelerate deployment or establish a more aggressive capital-allocation policy.
Read the original 8-K on SEC EDGAR ↗